Get the Stockscreener App
6.74
1.03%
-0.07
After Hours:
6.70
-0.04
-0.59%
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc stock is traded at $6.74, with a volume of 1.80M.
It is down -1.03% in the last 24 hours and up +0.90% over the past month.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
See More
Previous Close:
$6.81
Open:
$6.75
24h Volume:
1.80M
Relative Volume:
0.79
Market Cap:
$2.50B
Revenue:
$9.47B
Net Income/Loss:
$-178.00M
P/E Ratio:
-14.04
EPS:
-0.48
Net Cash Flow:
$1.01B
1W Performance:
+8.89%
1M Performance:
+0.90%
6M Performance:
+24.35%
1Y Performance:
-27.21%
1-Day Range:
$6.7201
$6.92
1-Week Range:
$5.875
$7.175
52-Week Range:
$4.25
$9.82
Bausch Health Companies Inc Stock (BHC) Company Profile
Name
Bausch Health Companies Inc
Sector
Phone
514-744-6792
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
6.74 | 2.52B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Jul-10-24 | Initiated | Raymond James | Mkt Perform |
| Sep-20-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jul-29-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-29-22 | Downgrade | Truist | Buy → Hold |
| Jul-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-13-22 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-17-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-22-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-17-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-24-20 | Initiated | Citigroup | Buy |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-22-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-02-19 | Initiated | Goldman | Neutral |
| Oct-25-19 | Initiated | Cowen | Outperform |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Aug-15-19 | Upgrade | TD Securities | Hold → Buy |
| Jul-19-19 | Initiated | Wolfe Research | Outperform |
| Jun-11-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Jan-02-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Nov-05-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-18 | Upgrade | Piper Jaffray | Underweight → Neutral |
View All
Bausch Health Companies Inc Stock (BHC) Latest News
Bausch Health raises 2025 revenue guidance to $5B-$5.1B while strengthening Solta and Salix growth - MSN
Why pension funds invest in Bausch Health Companies Inc. (BVF) stockPortfolio Gains Summary & Low Risk High Win Rate Picks - newser.com
Is Bausch Health Companies Inc. stock a buy on dips2025 Key Lessons & Growth Focused Entry Reports - newser.com
Why Bausch Health Companies Inc. stock could outperform in 2025July 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
Can Bausch Health Companies Inc. stock rebound after recent weakness2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Is Bausch Health Companies Inc. stock a smart buy before Fed meetingDollar Strength & Growth Focused Investment Plans - newser.com
Bausch Health Companies Inc. (NYSE:BHC) Q3 2025 Earnings Call Transcript - MSN
Bausch Health Companies Inc. (BHC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Why analysts remain bullish on Bausch Health Companies Inc. stockJuly 2025 News Drivers & Accurate Trade Setup Notifications - newser.com
Is Bausch Health Companies Inc. stock attractive for income investorsWeekly Stock Report & Momentum Based Trading Ideas - newser.com
Is Bausch Health Companies Inc. stock supported by strong fundamentals2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Risk vs reward if holding onto Bausch Health Companies Inc.Earnings Beat & Free Weekly Watchlist of Top Performers - newser.com
Using Bollinger Bands to evaluate Bausch Health Companies Inc.Market Rally & Consistent Growth Equity Picks - newser.com
How supply chain issues affect Bausch Health Companies Inc. stockJuly 2025 Patterns & Capital Efficiency Focused Ideas - newser.com
Gruss & Co. LLC Takes $799,000 Position in Bausch Health Cos Inc. $BHC - MarketBeat
What RSI levels show for Bausch Health Companies Inc. stockWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
MUFG Securities EMEA plc Takes Position in Bausch Health Cos Inc. $BHC - MarketBeat
Published on: 2025-11-03 05:34:12 - newser.com
Is Bausch Health Companies Inc. stock positioned for digital transformationJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
Real time pattern detection on Bausch Health Companies Inc. stockQuarterly Performance Summary & Reliable Volume Spike Trade Alerts - newser.com
Is Bausch Health Companies Inc. stock inflation resilient2025 Support & Resistance & Fast Gaining Stock Reports - newser.com
Published on: 2025-11-03 02:08:24 - newser.com
Is Bausch Health Companies Inc a good long term investmentVolatility Index Analysis & Explosive Capital Gains - earlytimes.in
How to interpret RSI for Bausch Health Companies Inc. stock2025 Technical Patterns & Smart Investment Allocation Insights - newser.com
How Bausch Health Companies Inc. stock reacts to fiscal policiesJuly 2025 Earnings & Daily Risk Controlled Trade Plans - newser.com
Will Bausch Health Companies Inc. stock sustain high P E ratios2025 Retail Activity & Safe Capital Growth Tips - newser.com
Should you wait for a breakout in Bausch Health Companies Inc.Portfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com
Is Bausch Health Companies Inc. (BVF) stock worth buying before Fed actionWeekly Investment Recap & Entry Point Confirmation Alerts - newser.com
Bausch Health Cos (NYSE:BHC) Upgraded at Wall Street Zen - MarketBeat
What macro factors could drive Bausch Health Companies Inc. (BVF) stock higherMarket Growth Report & Fast Momentum Entry Tips - newser.com
Bausch Health (NYSE:BHC): Assessing Valuation After Strong Earnings, Upgraded Guidance, and Pipeline Progress - Sahm
Bausch Health Cos (NYSE:BHC) Shares Gap UpHere's What Happened - MarketBeat
Bausch Health Companies (TSE:BHC) Stock Price Up 15.9%Here's Why - MarketBeat
5 Undervalued Stocks Under $10 Poised for Double-Digit Rebounds - Investing.com
Europe Photodynamic Therapy Market Size, Trends, Leading Applications and Pricing Benchmarks (2025-2033) Featuring Gladerma, Sun Pharmaceutical, Biofrontera, Lumibird, Bausch Health Companies and More - GlobeNewswire
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Wave Life Sciences (WVE) and Bausch Health Companies (BHC) - The Globe and Mail
Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC), Thermo Fisher (TMO) and Mineralys Therapeutics, Inc. (MLYS) - The Globe and Mail
Bausch Health Companies Inc Stock (BHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.60%
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):